Podiatrist Tested

Is the ASICS Gel-Kayano 32 Good for Plantar Fasciitis?

Buying note, September 2026: a newer version exists. ASICS released the GEL-KAYANO 33 on 1 June 2026 at $170 and has removed the Kayano 32 from its own site, although retailers still carry it. Everything on this page about the 32’s published design still describes the shoe you would be buying at a discount, and we have not yet analysed the 33. Check the price gap before you decide.

Written and medically reviewed by · Last reviewed 2 October 2026

We earn a commission if you buy through links on this page, including Amazon links paid by brand partners through Levanta, at no cost to you. As an Amazon Associate I earn from qualifying purchases. How we make money

By Tom Biernacki, DPM, FACFASDouble board-certified foot & ankle surgeonUpdated 2 Oct 2026

Spec analysis — not yet tested · Published September 2026

Spec analysis — not yet tested. This shoe has not been through the Podiatrist Tested bench. Every figure below is the manufacturer’s own published number, attributed by name; the reasoning is clinical judgement about the published design, not our measurement. No score, no seal. How we test →

The ASICS Gel-Kayano is the shoe people buy when they have decided they need support. It is the flagship stability trainer in one of the largest running ranges in the world, and for two decades it has been the default recommendation for a foot that rolls inward. So “is the Kayano good for plantar fasciitis” is really a question about whether support helps plantar fasciitis — and the answer to that changed in 2023 in a way almost nobody has noticed.

A note on why this page exists. When we looked at what currently answers this question, the results were the ASICS product page itself, a post in a Facebook group, three eBay listings, and two affiliate blogs at domain authority two and eighteen. There is no clinician anywhere on that page of results. This is a question a lot of people are asking and nobody qualified is answering it.

Read this before you buy anything

The evidence for arch support and heel cushioning was downgraded in 2023

The current clinical practice guideline for this condition is Heel Pain — Plantar Fasciitis: Revision 2023, published in the Journal of Orthopaedic & Sports Physical Therapy by the Academy of Orthopaedic Physical Therapy and the American Academy of Sports Physical Therapy. We read the guideline itself rather than a summary of it, and this is what changed.

The 2014 version said, at grade A (strong evidence): “Clinicians should use foot orthoses, either prefabricated or custom fabricated/fitted, to support the medial longitudinal arch and cushion the heel…”

The 2023 revision replaced that with two weaker statements:

  • Grade B — “Clinicians should not use orthoses, either prefabricated or custom fabricated/fitted, as an isolated treatment for short-term pain relief in individuals with plantar fasciitis.”
  • Grade C — “Clinicians may use orthoses… when combined with other treatments…”

Footwear itself appears in that guideline exactly twice, and both times at its weakest grades: under the grade C orthoses heading, as “an over-the-counter heel cushion, footwear modification that provide heel cushioning, especially in individuals with decrease shock absorption capacity”; and under patient education at grade E — theoretical or foundational evidence — as “footwear options to mitigate commonly occurring weight loading stresses.”

There is no grade A or grade B footwear recommendation in the guideline. What does carry grade A: plantar-fascia-specific and calf stretching, manual therapy, taping as an adjunct, and night splints for people who consistently have first-step morning pain.

So the honest framing for every page like this one, ours included: a shoe is a comfort and symptom-management variable. It is not the treatment. Anyone telling you a particular shoe cures plantar fasciitis is claiming more than the evidence supports.

Why that downgrade lands hardest on this particular shoe. The Kayano is sold on medial support and arch control. That is precisely the intervention the 2014 guideline endorsed at grade A — orthoses to “support the medial longitudinal arch and cushion the heel” — and precisely what the 2023 revision demoted to “should not use as an isolated treatment” at grade B. The support premise has not been shown to be wrong. It has been shown to be weaker than we thought, and specifically insufficient on its own.

Newer model: ASICS released the Gel-Kayano 33 on 1 June 2026. A lab measured it about 3 mm lower at the heel and a fifth softer, on the same 8 mm stated drop; our Kayano 32 vs 33 comparison sets out who should upgrade. This page still describes the 32.

Two facts that should change how you read every shoe review

First: it is not an inflammation. Despite the name, the histology shows myxoid degeneration, collagen disarray, micro-tears and granulation tissue, with a notable absence of the classic inflammatory picture. Clinicians increasingly call it plantar fasciopathy for that reason. This matters commercially, because it means any product sold to you on the promise of “reducing inflammation” in your heel is aimed at a mechanism that is largely not there.

Watch: Plantar Fasciitis Mistakes That Make Heel Pain WorseThe heel-pain mistakes a stability shoe cannot fix on its own.Michigan Foot Doctors · general education, not a diagnosis · editorial policy

Second: roughly three quarters of cases resolve on their own within twelve months. That single fact quietly destroys most of the shoe testimonials you will read. If someone buys a shoe, and their heel pain improves over the following months, the most likely explanation is the natural history of the condition rather than the shoe. Uncontrolled before-and-after stories — including glowing ones about the shoe on this page — carry almost no information. It is also why we are not going to show you any.

Does arch support reduce load on the plantar fascia?

Here the mechanical evidence is actually more encouraging than the clinical evidence, and the gap between those two things is the whole story of this page.

The most useful single finding comes from Kogler and colleagues, who compared different ways of altering the foot’s position and measured what happened to strain in the plantar aponeurosis itself. Block-shaped heel lifts produced no significant change in fascial strain. Contoured shanks supporting the arch did reduce it. That is a clean result and it points somewhere specific: if you want to unload the plantar fascia mechanically, contour under the arch is the lever, and heel height is not.

Which sounds like a straightforward endorsement of a supportive shoe — until you notice what it is actually an endorsement of. Kogler was measuring contoured shanks and orthotic devices, not the medial posting of a retail stability trainer. And when the same idea has been taken into clinical trials in patients, the results have been enough to move the guideline in the opposite direction: from “clinicians should use” in 2014 to “clinicians should not use as an isolated treatment” in 2023, with a systematic review finding no meaningful difference between prefabricated and custom orthoses either.

There is a second reason to be careful about leaning on the shoe. Achilles tendon force has been calculated to account for around 65 per cent of total plantar fascia strain. The largest single contributor to the load on your heel is your calf, and no shoe addresses that. Calf stretching does, and it carries grade A.

Our reading: a stability shoe is a defensible choice if your foot genuinely overpronates, because that is what the shoe is built for, and controlling it is reasonable. It is not established as a treatment for plantar fasciitis, the guideline explicitly declines to endorse support as a stand-alone measure, and the mechanically supported version of “arch support” is a contoured device rather than a shoe.

What has actually been measured about shoes

Very little, and it is worth knowing exactly how little.

  • One direct footwear-design study in patients. Franettovich Smith and colleagues (Journal of Foot and Ankle Research, 2025) tested 29 women with plantar heel pain in a shoe with a 14 mm heel-to-toe pitch against one with a 4 mm pitch. The higher-pitch shoe reduced peak heel pressure by about 15 per cent. Five different insoles inside the test shoe produced no significant differences between them. Read the limitation carefully: this measured immediate pressure, not pain over time. It shows a shoe can change what your heel feels. It does not show that changing that changes the condition.
  • One randomised trial that went the other way. Reinstein and colleagues (Annals of Physical and Rehabilitation Medicine, 2024) randomised 52 people with persistent plantar heel pain to four weeks of treadmill walking either barefoot or in comfortable sports shoes. Both groups improved. The barefoot group improved more — morning pain fell 5.1 cm on a visual analogue scale versus 2.9 cm shod, with a larger gain in physical function. This is an inconvenient result for the entire supportive-shoe category and we are not going to pretend it does not exist. It was treadmill walking under supervision, not a recommendation to throw your shoes away.
  • Combination, not shoe alone. A systematic review of mechanical treatments found that rocker-soled shoes produced significant pain reduction when combined with customised insoles. The benefit attaches to the combination. No trial has shown a retail shoe on its own treating this condition.

What ASICS actually publishes — and the two things it does not

SpecificationMen’sWomen’s
Heel drop8 mm8 mm
Weight300 g / 10.58 oz
ASICS states no sample size
260 g / 9.17 oz
ASICS states no sample size
Heel / forefoot stackNot published by ASICS
FittingsStandard, Wide, Extra Wide — each a separate product codeStandard, Wide — separate product codes; no extra wide found
MidsoleFF BLAST™ PLUS foam
Support4D GUIDANCE SYSTEM™. ASICS US: “helps provide adaptive stability… a more supportive and balanced stride”
RockerNo rocker claim
MSRP$165.00 — the same across standard, wide and extra wide
ASICS’ own published figures. Widths are sold as separate product codes and ASICS labels them in words only; the 2E and 4E letters you see at retail are the retailers’ designations, not ASICS’.

Now the two silences, both of which matter for this condition.

  • ASICS publishes nothing about the heel counter or heel geometry. A firm heel counter is one of the things every article about heel pain tells you to look for, and for the flagship stability shoe of a major brand there is no published statement about it at all. The only structural support wording on the page is about the arch: “a reinforced tongue wing along the arch also provides additional comfort and support.” We are not going to assert something about the heel counter that the manufacturer has not stated.
  • ASICS describes the change from the Kayano 31 in direction only. Its words: the FF BLAST PLUS midsole “is combined with a higher midsole stack height while reducing it’s weight” [sic]. Higher than what, by how much, ASICS does not say — and it has retired the Kayano 31 product pages, so the previous figures can no longer be sourced from ASICS either. A 31-versus-32 stack comparison cannot currently be made from any manufacturer source.

One more thing worth knowing about the drop. The Kayano 32 runs 8 mm. Older Kayanos sat higher. If you are coming back to the model after a few years, or stepping down from a boot or a heel-lifted shoe, this is a lower heel than you may remember, and that transition is worth making gradually rather than overnight.

So who is this shoe actually for

A reasonable pick if…

  • You genuinely overpronate. This is what the shoe is built to do, and the guideline’s own diagnostic criteria list an abnormal foot posture score as a feature of this condition. If your foot rolls inward, controlling that is sensible on its own terms.
  • You need a wide or extra-wide stability shoe. The men’s Kayano 32 is one of the few flagship stability trainers offered in an extra-wide code, and it is priced the same as the standard fitting.
  • You are going to use it alongside other treatment. That is the exact condition under which the guideline permits support at grade C — combined, not alone. Pair it with the stretching that carries grade A.

Look elsewhere if…

  • You do not overpronate. Buying a stability shoe because you have heel pain is a category error — stability addresses how your foot moves, not why your heel hurts. The neutral Gel-Nimbus 28 is the cushioned option in the same range.
  • You are relying on the shoe to be the treatment. This is the specific thing the 2023 guideline stopped endorsing.
  • You want a firm heel counter you can verify. ASICS publishes nothing about it. You would have to squeeze the shoe yourself in a shop.
  • You are a woman who needs extra wide. We found wide but no extra-wide women’s code for this model.

Check price on Amazon (men’s)Paid link. We earn a commission at no extra cost to you; commissions never influence a score, a ranking or the seal. Price and availability change, so check the listing.
Check price on Amazon (women’s)Paid link. We earn a commission at no extra cost to you; commissions never influence a score, a ranking or the seal. Price and availability change, so check the listing.

Our full ASICS Gel-Kayano 32 spec analysis covers the shoe outside this condition, and best shoes for overpronation deals with the movement problem the Kayano is actually designed for.

What actually carries the strongest evidence

If you only act on one section of this page, make it this one. These are the grade A recommendations from the 2023 guideline — the interventions with a preponderance of high-quality evidence behind them:

  • Plantar-fascia-specific stretching, plus calf stretching. In DiGiovanni’s two-year follow-up, 94 per cent of patients reported pain reduced or eliminated and none went on to surgery. Note honestly that everyone in that trial also received a prefabricated insole and a short course of anti-inflammatory medication, so it is not a clean test of stretching alone.
  • Manual therapy directed at the joints and soft tissue of the lower limb, with emphasis on improving ankle dorsiflexion.
  • Taping, rigid or elastic, in conjunction with other treatment, for short-term relief.
  • Night splints for one to three months, specifically for people who consistently have pain with the first steps in the morning. Worth flagging a disagreement here: the guideline grades this A, but American Family Physician called the role of night splints “inconclusive” and an umbrella review found no difference against orthoses. We are giving you the guideline grade and the dissent.

There is also a mechanical reason the calf keeps appearing. In a study of rocker shoes, changes in Achilles tendon force accounted for about 65 per cent of total plantar fascia strain. The calf drives the load on your heel far more than most footwear marketing acknowledges — which is part of why stretching outranks shoes in the evidence.

When it is not plantar fasciitis

Do not buy a shoe for these — get assessed. Heel pain that is not worst on the first steps of the day; pain that does not ease as you warm up; night pain or pain at rest; a sudden pop or an inability to put weight through the foot (fascial rupture, and a recognised complication of steroid injection); focal bony tenderness, especially after a recent jump in impact loading (calcaneal stress fracture); burning, tingling, numbness or radiating pain (nerve entrapment, including Baxter’s nerve and tarsal tunnel — the guideline’s own diagnostic criteria require negative tarsal tunnel tests before calling it plantar fasciitis); heel pain in both feet alongside morning stiffness elsewhere or inflammatory back and joint symptoms (spondyloarthritis); or no improvement at three months despite proper treatment, which is the point at which imaging is generally considered. The guideline also asks clinicians to look for fat-pad atrophy and proximal plantar fibroma when a case is atypical or is not resolving.

Common questions

Is the Kayano good for plantar fasciitis?

It is a good stability shoe. Whether that helps your heel depends on whether you overpronate. The support premise itself was downgraded in the 2023 guideline from “should use” to “should not use as an isolated treatment” — so treat it as one part of a plan, not the plan.

Does the Kayano 32 have good arch support?

ASICS describes a 4D Guidance System providing “adaptive stability” and a reinforced tongue wing along the arch. What it does not publish is any figure you could compare against another shoe. The mechanical work that shows arch contour reducing fascial strain was done on contoured orthotic devices, not on retail stability shoes — that distinction matters.

Is the Kayano 32 lower than older Kayanos?

At 8 mm, yes, lower than the model historically ran. If you are returning to it after some years, expect a different feel at the heel and give it time.

Should I put an orthotic in it?

The guideline permits orthoses combined with other treatment at grade C, and explicitly not as an isolated treatment at grade B. A systematic review found no meaningful difference between prefabricated and custom, so starting with an over-the-counter device is reasonable. Note the Kayano already has its own support built in, so adding a device changes the fit.

How much stack does it have?

ASICS does not publish it. It says only that the 32 has a higher stack than the 31 while weighing less, without giving numbers for either — and the Kayano 31 pages have been retired, so the comparison cannot be sourced.

Sources

  • Koc TA Jr, et al. Heel Pain — Plantar Fasciitis: Revision 2023. Clinical Practice Guidelines linked to the ICF, Academy of Orthopaedic Physical Therapy and American Academy of Sports Physical Therapy, APTA. J Orthop Sports Phys Ther. 2023;53(12):CPG1–CPG39. — the 2014 grade A orthoses recommendation and its 2023 replacement by the grade B “should not use… as an isolated treatment” and grade C “may use… combined” statements; the grade C heel-cushioning footwear-modification bullet; the grade E patient-education footwear line; grade A status for stretching, manual therapy, taping and night splints. Read at source.
  • Plantar Fasciitis. StatPearls (NBK431073). — degenerative rather than inflammatory histology; first-step morning pain; approximately 75% resolve within 12 months; differential diagnosis.
  • Plantar Fasciitis (heel pain) review. American Family Physician, 2019. — “fasciopathy” framing; SORT ratings; differential table; three-month imaging threshold; night-splint dissent.
  • Franettovich Smith MM, et al. Immediate Effects of Footwear Design on In-Shoe Plantar Pressures, Impact Forces and Comfort in Women With Plantar Heel Pain. J Foot Ankle Res. 2025;18(2):e70055. — 29 women; 14 mm vs 4 mm pitch; ~15% heel peak pressure reduction; no differences between five insoles; immediate effects only.
  • Reinstein M, Weisman A, Masharawi Y. Barefoot walking is beneficial for individuals with persistent plantar heel pain: a single-blind randomized controlled trial. Ann Phys Rehabil Med. 2024;67:101786. — n=52; morning pain VAS improvement 5.1 cm barefoot vs 2.9 cm shod.
  • Greve C, et al. Biomechanical effects of rocker shoes on plantar aponeurosis strain in patients with plantar fasciitis and healthy controls. PLOS ONE. 2019;14(10):e0222388. — no significant reduction in plantar aponeurosis strain between shoe conditions (p = .089, n = 16); Achilles tendon force accounted for 65 ± 2% of total strain.
  • Effectiveness of Mechanical Treatment for Plantar Fasciitis: A Systematic Review. J Sport Rehabil. 2020;29(5). — 43 studies; rocker-soled shoes with customised insoles produced significant pain reduction; prefabricated and custom insoles comparable.
  • DiGiovanni BF, et al. Plantar fascia-specific stretching exercise improves outcomes in patients with chronic plantar fasciitis: two-year follow-up. J Bone Joint Surg Am. 2006;88-A(8):1775–1781. — 94% pain reduced or eliminated at two years; no surgery; note both arms also received prefabricated insoles.
  • Rasenberg N, et al. Efficacy of foot orthoses for the treatment of plantar heel pain: a systematic review and meta-analysis. Br J Sports Med. 2018;52(16):1040–1046. — no difference between prefabricated and custom orthoses on short-term pain.
  • American Podiatric Medical Association Seal of Acceptance database, apma.org. — checked directly for every seal claim on this page.
  • Kogler GF, et al. Biomechanics of longitudinal arch support mechanisms in foot orthoses and their effect on plantar aponeurosis strain. Clinical Biomechanics. — block heel lifts produced no significant change in plantar fascia strain; contoured shanks supporting the arch did reduce it. As collated in Richie D, Heel Elevation In The Shoe: What The Literature Reveals, Podiatry Today / HMP Global.
  • ASICS product pages for the Gel-Kayano 32 — men’s 1011C052, women’s 1012B838, Wide 1011C051 and 1012B839, Extra Wide 1011C054 — asics.com US and Canada, September 2026. — heel drop, weights, midsole, MSRP, the 4D Guidance System wording, the Kayano 31 change statement, and the absence of stack heights, heel-counter description and width letter codes.

Page type: spec analysis — not yet tested · This shoe has not been measured on our bench · All figures manufacturer-published and attributed; retailer figures labelled as such · Last verified September 2026 · By Dr. Thomas Biernacki, DPM

Sourced, not guessed

Reviews for Plantar Fasciitis

Individual shoe pages state their evidence tier, published measurements and who should skip them.

Dansko

Dansko XP 2.0

Spec Analysis

Occupational clog with a removable dual-density footbed and slip-resistant outsole — not yet tested.

$165Not scoredRegular and Wide by style
Orthofeet

Orthofeet Coral

Spec Analysis

Extra depth, published quarter-inch removable insole, widths A to 4E depending on colour, 15.7 mm drop — not yet tested.

$119Not scoredW: A/B/D/2E/4E
Skechers

Skechers GO WALK Arch Fit 2.0

Spec Analysis

Removable Arch Fit insole, hands-free entry, APMA Seal on some styles — not yet tested.

Not scoredStandard and Wide by style; X-Wide…

All Plantar Fasciitis shoes

Our funding and evidence policy

We earn affiliate commissions from qualifying purchases. Our policy is to assess published evidence and fit needs rather than rank products by commission rate. Current reviews are specification analyses; see our method for their limits.